Differential expression of E-cadherin in metastatic lesionscomparing to primary oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 35, Issue 10, 2006, Pages 589-594

  Hung, K F ^a,b   Chang, C S ^a,b   Liu, C J ^b,c   Lui, M T ^a,b   Cheng, C Y ^c   Kao, S Y ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Carcinoma; E cadherin; Metastasis; Mouth; prognosis

Indexed keywords

UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DYNAMICS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOPLAKIA; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; MULTIVARIATE ANALYSIS; NECK DISSECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; SEX FACTORS;

EID: 33749512983     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00474.x     Document Type: Article

References (25)

1. Lo WL, Kao SY, Chi LY, Wong YK, Chang RC. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 2003; 61: 751-8.
2. Kowalski PJ, Rubin MA, Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 2003; 5: R217-22.
3. Palacios F, Tushir JS, Fujita Y, D'Souza-Schorey C. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 2005; 25: 389-402.
4. Imai T, Horiuchi A, Shiozawa T et al. Elevated expression of E-cadherin and alpha-, beta-, and gamma-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 2004; 35: 1469-76.
5. Kase S, Sugio K, Yamazaki K, Okamoto T, Yano T, Sugimachi K. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 2000; 6: 4789-96.
6. Escaffit F, Perreault N, Jean D et al. Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance. Exp Cell Res 2005; 302: 206-20.
7. Kuefer R, Hofer MD, Gschwend JE et al. The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin Cancer Res 2003; 9: 6447-52.
8. Prenzel KL, Baldus SE, Monig SP et al. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes. Cancer 2004; 100: 1909-17.
9. Lin YC, Wu MY, Li DR, Wu XY, Zheng RM. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World J Gastroenterol 2004; 10: 3235-9.
10. Wu H, Lotan R, Menter D, Lippman SM, Xu XC. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res 2000; 20: 1385-90.
11. Kantak SS, Kramer RH. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 1998; 273: 16953-61.
12. Hung KF, Lin SC, Liu CJ, Chang CS, Chang KW, Kao SY. The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med 2003; 32: 461-7.
13. Chen PH, Ko YC, Yang YH et al. Important prognostic factors of long-term oropharyngeal carcinoma survivors in Taiwan. Oral Oncol 2004; 40: 847-55.
14. Farmer I, Freysdottir J, Dalghous AM, Fortune F. Expression of adhesion and activation molecules in human buccal epithelial cell lines and normal human buccal epithelium in situ. J Oral Pathol Med 2001; 30: 113-20.
15. Yokoyama K, Kamata N, Hayashi E et al. Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 2001; 37: 65-71.
16. Takes RP, Baatenburg De Jong RJ, Alles MJ et al. Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 512-8.
17. Lim SC, Zhang S, Ishii G et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 2004; 10: 166-72.
18. Nakanishi Y, Akimoto S, Sato Y, Kanai Y, Sakamoto M, Hirohashi S. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl Immunohistochem Mol Morphol 2004; 12: 323-8.
19. Xie K, Huang S. Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis 2003; 20: 31-43.
20. Doglioni CPS, Demontis S. Alterations of beta-catenin pathway in non-melanoma skin tumors: Loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation. Am J Pathol 2003; 163: 2277-87.
21. Lu Y, Xu YC, Shen J et al. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 2005; 11: 56-60.
22. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275: 2727-32.
23. Lu Z, Ghosh S, Wang Z, Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003; 4: 499-515.
24. Jiang D, Ying W, Lu Y et al. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 2003; 3: 724-37.
25. Akhtar N, Hotchin NA. RAC1 regulates adherens junctions through endocytosis of E-cadherin. Mol Biol Cell 2001; 12: 847-62.